Sign In

Stephen Spellman

Vice President, Research at NMDP

Stephen Spellman is a prominent figure in the field of blood and marrow transplant research. He currently serves as the Vice President of Research at the National Marrow Donor Program (NMDP) and holds the position of Senior Scientific Director at the Center for International Blood and Marrow Transplant Research (CIBMTR).14

Professional Background

Spellman's expertise lies in immunogenetics and observational research related to hematopoietic cell transplantation.6 His work focuses on expanding access to transplant therapies, particularly for diverse populations using mismatched unrelated donor therapies.5

Roles and Responsibilities

As Vice President of Research at NMDP, Spellman oversees various research initiatives aimed at improving outcomes for patients requiring cellular therapies. In his role as Senior Scientific Director at CIBMTR, he provides leadership and vision for the organization's programs and activities.1

Research and Contributions

Spellman has made significant contributions to the field, as evidenced by his extensive publication record. He has been cited by 12,943 other researchers and has authored or co-authored 288 publications.7 His research interests include:

  • Immunobiology
  • Observational studies in hematopoietic cell transplantation
  • Graft sources and graft-versus-host disease3

Professional Network

Stephen Spellman maintains an active presence on LinkedIn, where he has over 500 connections.2 His LinkedIn profile can be found under the username "stephen-spellman-a716906".

Stephen Spellman's multifaceted role in research leadership and his contributions to the field of cellular therapy make him a key figure in advancing the science and practice of blood and marrow transplantation.

Highlights

Jul 17 · linkedin

New research from CIBMTR demonstrating equivalent outcomes for matched and mismatched unrelated donor transplantation using a novel post-transplant cyclophosphamide-based graft vs host disease (GVHD) prevention strategy. Greatly expands access to all patients in need of allogeneic transplant regardless of ancestry and significantly improves GVHD-free, relapse-free survival compared to matched unrelated donor transplants using traditional GVHD prevention approaches. We are making significant progress towards ensuring a donor for all in need. Strong work!

Apr 8 · linkedin

NMDP/Be The Match is hiring! Seeking a Nurse Practitioner with experience allogeneic transplant. Consider joining our team! https://lnkd.in/g6HHJSmq

Related Questions

What are Stephen Spellman's main research interests?
How has Stephen Spellman contributed to the field of cellular therapy?
What are some notable achievements of Stephen Spellman at NMDP?
How does Stephen Spellman's role at CIBMTR impact his work at NMDP?
What is Stephen Spellman's educational background?
Stephen Spellman
Stephen Spellman, photo 1
Stephen Spellman, photo 2
Add to my network

Location

Minneapolis, Minnesota, United States